Zachary Warren Archive
-
May 23, 2013
Blood test for autism could speed diagnosis
Vanderbilt University is part of a multi-site autism clinical study designed to evaluate the effectiveness of a blood test that aims to screen children for referral for autism spectrum disorder evaluation (ASD) earlier and more accurately. -
May 9, 2013
NIH grants bolster autism research, treatment efforts
Researchers at Vanderbilt University have received grant awards from the National Institutes of Health as part of the Autism Centers of Excellence (ACE) research program. The NIH announced grant awards of $100 million over five years to 11 centers nationwide, three of which feature projects from Vanderbilt Kennedy Center investigators, to further studies on autism treatment and intervention. -
March 23, 2013
Humanoid robot helps train children with autism
An interdisciplinary team of mechanical engineers and autism experts at Vanderbilt University have developed an adaptive robotic system and used it to demonstrate that humanoid robots can be powerful tools for enhancing the basic social learning skills of children with autism. -
March 7, 2013
Warren lands AAIDD early career award
Zachary Warren, Ph.D., has been named to receive the American Association on Intellectual and Developmental Disabilities' (AAIDD) 2013 Early Career Award. -
September 24, 2012
Little evidence supports medical treatment options for adolescents with autism
Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population. -
August 27, 2012
Little evidence supports autism treatment options in adolescents
There is insufficient evidence to support findings, good or bad, for therapies currently used in adolescents and young adults with autism. -
April 4, 2011
Better tools needed to target autism treatments for children
Although an evaluation of existing treatments for children with autism spectrum disorders found positive results in some studies, better information is needed to target the right treatments to specific children.